Tekrarlayan prostat biyopsilerinin komplikasyon oranlarına etkisi
Amaç: Tekrarlayan transrektal ultrasonografi eşliğinde yapılan prostat biyopsilerinin komplikasyon oranlarına etkisinin olup olmadığı inceledik. Gereç ve Yöntem: Haziran 2010-Haziran 2014 tarihleri arasında transrektal ultrasonografi eşliğinde prostat biyopsisi yapılan 793 hasta çalışmaya dahil edildi. Hastalar ilk defa (Grup-1) ve daha önce biyopsi yapılanlar (Grup-2) olarak ikiye ayrıldı. Biyopsi sonrası her iki grup arasındaki komplikasyon oranları değerlendirildi. p
The effect of repeated prostate biopsies to complication rates
Aim: We examined the effect of repeated transrectal ultrasound guided prostate biopsies to complication rates. Materials and Methods: Seven hundred and ninety three patients who underwent transrectal ultrasound guided prostate biopsies between June 2010 and June 2014 were enrolled in the study. The patients divided into two groups: Patients who were biopsied for the first time (Group-1) and who were biopsied previously (Group-2). The complication rates were evaluated between two groups. p<0.05 values were regarded as statistically significant. Results: There were 668 patients (%84.2) in Group 1 and 125 patients (%15.8) in Group-2. Minor complication rates in Group-1 and Group-2 were %67.8 and %81.6, respectively (p=0.002). Major complication rates were %1.0 in Group-1 and %4.0 in Group-2 (p=0.013). Both results were statistically significant. Hematuria and infection rates were also statistically significant between the two groups (p=0.019 and p=0.039, respectively). Conclusion: Hematuria and infection rates increase after repeated prostate biopsies. Patients should be informed and measures should be reconsidered
___
- 1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2012;62(1):10-29.
- 2. Durkan GC, Greene DR. Diagnostic dilemmas in ditection of prostate cancer in patients undergoing transrectal ultrasound- guided needle biopsy of the prostate. Prostate Cancer Prostatic Dis 2000;3(1):13-20.
- 3. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142(1):71-4.
- 4. Djavan B, Waldert M, Zlotta A, et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol 2001;166(3):856-60.
- 5. Eskicorapci SY, Guliyev F, Islamoglu E, Ergen A, Ozen H. The effect of prior biopsy scheme on prostate cancer detection for repeat biopsy population: Results of the 14-core prostate biopsy technique. Int Urol Nephrol 2007;39(1):189-95.
- 6. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011;59(1):61-71.
- 7. Kam SC, Choi SM, Yoon S, et al. Complications of transrectal ultrasound-guided prostate biopsy: Impact of prebiopsy enema. Korean J Urol 2014;55(11):732-6.
- 8. Efesoy O, Bozlu M, Çayan S, Akbay E. Complications of transrectal ultrasound-guided 12-core prostate biopsy: A single center experience with 2049 patients. Turk J Urol 2013;39(1):6-11.
- 9. Berger AP, Gozzi C, Steiner H, et al. Complication rate of transrectal ultrasound guided prostate biopsy: A comparison among 3 protocols with 6, 10 and 15 cores. J Urol 2004;171(4):1478-80.
- 10. Rietbergen JB, Kruger AE, Kranse R, Schröder FH. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: Evaluation of complication rates and risk factors within a population based screening program. Urology 1997;49 (6):875-80.
- 11. Avcı A, Özgök A, Erdem H, et al. Transrektal ultrasonografi eşliğinde yapılan 12 kor prostat biyopsisinde komplikasyonlar. Üroloji Bülteni 2004;15(2):153-8.
- 12. Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schrder FH. Complication rates and risk factors of 5802 transrectal ultrasound guided sextant biopsies of the prostate within a population-based screening program. Urology 2002;60(5):826-30.
- 13. van den Heuvel S, Loeb S, Zhu X, et al. Complications of initial prostate biopsy in a European randomized screening trial. Am J Clin Exp Urol 2013;1(1):66-71.
- 14. Ehdaie B, Vertosick E, Spaliviero M, et al. The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. J Urol 2014;191(3):660-4.
- 15. van den Bergh RC, Ahmed HU, Bangma CH, Cooperberg MR, Villers A, Parker CC. Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: A systematic review. Eur Urol 2014;65(6):1023-31.